What is Digital Therapeutics? Making sense of the alphabet soup sdlcpartners.com

Digital Therapeutics (DTx) encompasses evidence-based software products prescribed by a physician to treat, manage, and prevent diseases. Since 2017, the FDA has approved ~40 digital therapeutics. And, with the success of telehealth and remote monitoring during the pandemic, digital therapeutics are accelerating in investment and adoption. In the first of two insights, we’ll define the space, providing some market sizing and what’s trending now. The second insight will highlight the FDA’s evolving approach, how provider and payer organizations use digital therapeutics, and the clinical areas in the DTx product pipeline.